Futuximab Biosimilar – Anti-EGFR domain III , ERBB1 mAb – Research Grade

Reference:
Product nameFutuximab Biosimilar - Anti-EGFR domain III , ERBB1 mAb - Research Grade
SourceCAS 1310460-85-5
SpeciesChimeric
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsFutuximab,DS 992,Sym 004 (combination of modotuximab and futuximab),EGFR domain III , ERBB1,anti-EGFR domain III , ERBB1
ReferencePX-TA1293
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Futuximab Biosimilar - Anti-EGFR domain III /ERBB1 mAb - Research Grade

General information on Anti-EGFR domain III /ERBB1[Homo sapiens] (Futuximab) Monoclonal Antibody

Futuximab is investigated for the treatment of Solid Tumors.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Futuximab Biosimilar – Anti-EGFR domain III , ERBB1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

EGFR protein – Epidermal growth factor receptor(EGFR)
Antigen

EGFR protein – Epidermal growth factor receptor(EGFR)

PX-P4586 210€
Epidermal growth factor receptor(EGFR)
Antigen

Epidermal growth factor receptor(EGFR)

PX-P4657 210€
EGFR / ERBB1 / HER1, C-His, recombinant protein
Antigen

EGFR / ERBB1 / HER1, C-His, recombinant protein

PX-P5701 320€
Stable Isotope Labelled Futuximab Biosimilar – Anti-EGFR  domain III /ERBB1 mAb – Research Grade
SIL

Stable Isotope Labelled Futuximab Biosimilar – Anti-EGFR domain III /ERBB1 mAb – Research Grade

PX-TA1293-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products